Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

F. Hoffmann-La Roche AG discovers HBV capsid inhibitors

May 4, 2017

Bristol-Myers Squibb presents apelin receptor agonists

May 4, 2017

French researchers present azaphenantrene analogues

May 3, 2017

Gruenenthal identifies Cav2.2 channel blockers

May 3, 2017

Agency for Science, Technology and Research (A*STAR) patents SMYD3 inhibitors

May 3, 2017

GlaxoSmithKline divulges BRD4 inhibitors

May 2, 2017

Bristol-Myers Squibb presents PD-L1/PD-1 and/or PD-L1/CD80 interaction inhibitors

May 2, 2017

Hetero Research Foundation identifies antiviral agents

May 2, 2017

Almirall discovers TRPA1 antagonists

May 2, 2017

Jiangsu Nhwaluokang Pharmaceutical Research & Development patents etomidate derivatives

May 2, 2017

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...